Faculty Research 1990 - 1999

Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus.

Document Type

Article

Publication Date

1999

Keywords

Cell-Line, Chromosome-Mapping, Clone-Cells, Cytotoxicity-Tests-Immunologic, Cytotoxicity-Immunologic: ge, Female, Immunodominant-Epitopes: ge, im, Male, Mice, Mice-Congenic, Mice-Inbred-C3H, Mice-Inbred-C57BL, Minor-Histocompatibility-Antigens: ge, Minor-Histocompatibility-Loci: ge, im, Oligopeptides: ge, im, Organ-Specificity: im, SUPPORT-U-S-GOVT-P-H-S, T-Lymphocytes-Cytotoxic: im

First Page

4502

Last Page

4510

JAX Source

J Immunol 1999 Apr 15;162(8):4502-10

Grant

RO1AI28802/AI/NIAID

Abstract

Of the many minor histocompatibility (H) Ags that have been detected in mice, the ability to induce graft vs host disease (GVHD) after bone marrow transplantation is restricted to a limited number of immunodominant Ags. One such murine Ag, B6dom1, is presented by the H2-Db MHC class I molecule. We present biochemical evidence that the natural B6dom1 peptide is indistinguishable from AAPDNRETF, and we show that this peptide can be isolated from a wide array of tissues, with highest levels from the lymphoid organs and lung. Moreover, we employ a novel, somatic cell selection technique involving CTL-mediated immunoselection coupled with classical genetics, to show that B6dom1 is encoded by the H7 minor H locus originally discovered approximately 40 years ago. These studies provide a molecular genetic framework for understanding B6dom1, and exemplify the fact that mouse minor H loci that encode immunodominant CTL epitopes can correspond to classical H loci originally identified by their ability to confer strong resistance to tumor transplantation. Additionally, these studies demonstrate the utility of somatic cell selection approaches toward resolving H Ag immunogenetics.

Please contact the Joan Staats Library for information regarding this document.

Share

COinS